BG
OPTR

BlackRock Group’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlackRock Group’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15,859
Closed -$200K – 2953
2013
Q3 		$200K Buy
15,859
+2,730
+21% +$36.2K ﹤0.01% 2482
2013
Q2 		$190K Buy
+13,129
New +$191K ﹤0.01% 2289

BlackRock Group's OPTR Position: Q4 2013 in Review

BlackRock Group sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 15,859 shares — an estimated $200K sold.

BlackRock Group first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $200K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlackRock Group reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 15,859 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $200K.
  • BlackRock Group first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BlackRock Group's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $200K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.